Azurity Pharmaceuticals - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Azurity Pharmaceuticals M&A Summary

Azurity Pharmaceuticals has acquired 4 companies of its own, including 3 in the last 5 years. A total of 3 acquisitions came from private equity firms.

Azurity Pharmaceuticals has acquired in 3 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

Azurity Pharmaceuticals Ownership

Who owns Azurity Pharmaceuticals?

Azurity Pharmaceuticals is owned by NovaQuest and QHP Capital. It was acquired on March 26, 2018.

Is Azurity Pharmaceuticals PE-backed?

Yes. Azurity Pharmaceuticals is owned by private equity investors NovaQuest and QHP Capital.

Was Azurity Pharmaceuticals formerly PE-backed?

Yes. Azurity Pharmaceuticals was formerly owned by 1 private investor.

Azurity Pharmaceuticals Business Overview

Where is Azurity Pharmaceuticals headquartered?

Azurity Pharmaceuticals is headquartered in Woburn, Massachusetts.

What sector is Azurity Pharmaceuticals in?

Azurity Pharmaceuticals is a life science company.

When was Azurity Pharmaceuticals founded?

Azurity Pharmaceuticals was founded in 1998.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity4
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1
  • M&A Advisors 3

Azurity Pharmaceuticals

Azurity Pharmaceuticals, Inc.

8 Cabot Road, Suite 2000,
Woburn, Massachusetts 01801
United States,
(781) 935-8141
www.azurity.com

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Azurity Pharmaceuticals was founded in 1998 and is based in Woburn, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.6/yr) # 1 1 - 1 - 1 4
Sell (0.0/yr) # - - - - - - 0
  4

Most Recent M&A

Company Date Value Type
Covis Group S.a. r.l 2025-03-14 - Add-on Acquisition
Luxembourg, Luxembourg · www.covispharma.com
Slayback Pharma LLC 2023-09-27 - Add-on Acquisition
Princeton, New Jersey · www.slayback-pharma.com
Arbor Pharmaceuticals LLC 2021-08-24 - Add-on Acquisition
Atlanta, Georgia · www.arborpharma.com
Silvergate Pharmaceuticals, Inc. 2019-06-12 - Add-on Acquisition
Greenwood Village, Colorado · www.silvergatepharma.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 4 (100%) - - -
Total 4 - - -

By Geo

State/Country Buy Value Sell Value
United States 3 - - -
  New Jersey 1 - - -
  Georgia 1 - - -
  Colorado 1 - - -
Luxembourg 1 - - -
Domestic 3 (75%) - - -
Cross-border 1 (25%) - - -
Total 4 - - -

Top M&A Advisors

Financial Deals
Greenhill & Co.
1
Legal Deals
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan
1
White & Case
1

M&A Connections

Deals
Acquired from
Investor(s)
75%
3 (75%)

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Azurity Pharmaceuticals

Life Science Companies